
The Dreeven is a smart robotic mobility assistance system that can easily be customized for an individual patient. [Image courtesy of Reev]
The Dreeven device is designed to “energize” knee braces, making them more helpful for the user. This offers greater benefits in standing and walking, reducing the stresses put on the body through the use of other devices. Reev aims to customize each device for the particular patient. Additionally, using AI, they hope to monitor and collect mobility information every day to monitor progress and adjust the device to help speed rehabilitation.

A Reev Sense sensor attached to a patient’s shoe [Image courtesy of Reev]
For the comfort of the user, Dreeven delivers a lightweight, intelligent motorization for knee assistance. This freedom helps users build confidence during rehabilitation and beyond. Dreeven’s gait assistance system uses biomarkers such as spatio-temporal analysis and correction for speed and cadence, stride length, swing and stance time, and stance symmetry. Kinematic analysis includes knee flexion angle and ankle flexion ankle.
Dreeven incorporates electro-hydraulic technology originating from the automotive industry and adapted for knee braces and medical care. It features three distinct operations: power generation via the motor, power transmission through the hydraulic actuator apparatus and power transfer to the knee through a sprocket cable link attached to the KAFO.

The maxon EC-i is one of the motors in maxon’s line of DC brushless motors used on Dreeven prototypes. [Image courtesy of Maxon]
According to Maxon and Reev, the entire system delivers a highly efficient, battery-operated mobility assisted device that can last about five hours without needing to be charged.
“Through the use of high-end components and expert in-house designs, Reev’s goal is to overcome the present limitations for current exoskeletons, including the weight of the system as well as the high purchase costs,” Maxon says. “And they are well on their way with the Dreeven mobility assistance device. As the company continues to perform more clinical studies, they continually improve on the device, and are confident in how well the system functions.”
The first Dreeven systems are expected to launch in 2026.


